En Es
Categories

T2 Biosystems

T2 Biosystems

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Bacteria® Pane ...
Products Covid-19Summary
Close

Covid-19 T2 Biosystems

Clinical Laboratory

SARS-CoV-2 Rt-PCR Test
T2SARS-CoV-2 Panel

The T2SARS-CoV-2 Panel is a qualitative reverse transcriptase-polymerase chain reaction (RT-PCR) and T2 Magnetic Resonance (T2MR) test designed for the direct detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens in transport media from individuals with signs and symptoms of COVID-19. It is run on the FDA-cleared T2Dx Instrument, the same instrument currently used to run the FDA-cleared T2Bacteria and T2Candida Panels.
More details
Close

About T2 Biosystems

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Bacteria® Panel, T2Candida® Panel, T2Resistance® Panel, and T2SARS-CoV-2™ Panel and are powered by the Company’s proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris™ Panel, T2Lyme™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens.

Recently updated

Benchtop Diagnostic System
T2Dx Instrument

The FDA-cleared T2Dx Instrument is a fully automated, walk away, clinical multiplex benchtop diagnostic system capable of running tests directly from whole blood. Powered by T2 Magnetic Resonance (T2MR) technology, it delivers species-specific results in 3 to 5 hours with no up-front sample preparation.
More details

SARS-CoV-2 Rt-PCR Test
T2SARS-CoV-2 Panel

The T2SARS-CoV-2 Panel is a qualitative reverse transcriptase-polymerase chain reaction (RT-PCR) and T2 Magnetic Resonance (T2MR) test designed for the direct detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens in transport media from individuals with signs and symptoms of COVID-19. It is run on the FDA-cleared T2Dx Instrument, the same instrument currently used to run the FDA-cleared T2Bacteria and T2Candida Panels.
More details

Fungal Diagnosis Blood Test
T2Candida Panel

The T2Candida Panel is the first and only FDA-cleared diagnostic test for the detection of sepsis-causing fungal pathogens, direct from whole blood. Species identification is provided within 3 to 5 hours of the first blood draw and independent of a positive blood culture, often before the second dose of antimicrobials is administered.
More details

Clinical Laboratory

Benchtop Diagnostic System
T2Dx Instrument

The FDA-cleared T2Dx Instrument is a fully automated, walk away, clinical multiplex benchtop diagnostic system capable of running tests directly from whole blood. Powered by T2 Magnetic Resonance (T2MR) technology, it delivers species-specific results in 3 to 5 hours with no up-front sample preparation.
More details

SARS-CoV-2 Rt-PCR Test
T2SARS-CoV-2 Panel

The T2SARS-CoV-2 Panel is a qualitative reverse transcriptase-polymerase chain reaction (RT-PCR) and T2 Magnetic Resonance (T2MR) test designed for the direct detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens in transport media from individuals with signs and symptoms of COVID-19. It is run on the FDA-cleared T2Dx Instrument, the same instrument currently used to run the FDA-cleared T2Bacteria and T2Candida Panels.
More details

Fungal Diagnosis Blood Test
T2Candida Panel

The T2Candida Panel is the first and only FDA-cleared diagnostic test for the detection of sepsis-causing fungal pathogens, direct from whole blood. Species identification is provided within 3 to 5 hours of the first blood draw and independent of a positive blood culture, often before the second dose of antimicrobials is administered.
More details

Bacterial Blood Test
T2Bacteria Panel

The T2Bacteria Panel is the first and only FDA-cleared and CE-marked panel to detect five clinically relevant bacterial pathogens in 3 to 5 hours, directly from a whole blood sample. T2Bacteria was shown to identify targeted species of bacteria ~66 hours faster than blood culture and has demonstrated a 5-day reduction ICU stay as well as a 4.8-day reduction in hospital length of stay.
More details
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions